Related Experiment Video
Updated: Aug 21, 2026

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs
Published on: October 31, 2025
Pulmonary alveolar proteinosis in children
1Service de Pneumologie et Allergologie Pédiatriques, Hôpital Necker Enfants Malades, 149 rue de Sèvres 75015, Paris, France. j.deblic@nck.ap-hop-paris.fr
Insights
Pulmonary alveolar proteinosis (PAP) is a rare pediatric lung disease. Bronchoalveolar lavage aids diagnosis, and while treatments exist, underlying mechanisms require further research.
Area of Science:
- Pediatric Pulmonology
- Rare Diseases
- Interstitial Lung Disease
Background:
- Pulmonary alveolar proteinosis (PAP) is a rare condition in children.
- It involves the buildup of lipoproteinaceous material in the alveoli.
- This leads to chronic interstitial lung disease.
Purpose of the Study:
- To summarize the key aspects of pediatric Pulmonary alveolar proteinosis.
- To highlight diagnostic methods and current therapeutic limitations.
- To underscore the need for further research into underlying mechanisms.
Main Methods:
- Review of diagnostic criteria for PAP.
- Analysis of clinical presentations and heterogeneity.
- Summary of current treatment modalities and their effectiveness.
Main Results:
- Bronchoalveolar lavage is crucial for diagnosis, showing milky fluid and PAS-positive material.
- PAP presents heterogeneously, with immediate-onset forms linked to SP-B deficiency.
- Postnatal-onset PAP can be primary or secondary, with variable progression.
Conclusions:
- Understanding the heterogeneity of PAP is essential for management.
- While therapeutic lung lavages are effective for severe cases, further research into GM-CSF pathways is needed.
- Accurate diagnosis and understanding of underlying mechanisms are critical for improving outcomes in pediatric PAP.
Abstract:
Pulmonary alveolar proteinosis (PAP) is a rare cause of chronic interstitial lung disease in children characterised by accumulation of a lipoproteinaceous material in the alveoli. Bronchoalveolar lavage is the key diagnostic tool, revealing a milky appearance of the return fluid and a periodic acid-Schiff staining material in the alveolar macrophages. PAP is a heterogeneous disease. Immediate-onset forms leading to early and fatal respiratory failure may be related to SP-B deficiency. Postnatal-onset PAP may be associated with various diseases or may be primary. The latter has a polymorphic progression from asymptomatic to uncontrollable respiratory failure. Recent studies have implicated GM-CSF and/or its receptor but the exact underlying mechanisms are still unknown. Therapeutic lung lavages are the only effective treatment for severe cases.
Related Concept Videos
Chronic Obstructive Pulmonary Disease II: Emphysema
Breathing
Pulmonary Edema II: Pathophysiology
Respiratory Syncytial Virus Disease
Pulmonary Cycle: Exhalation